These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34272972)

  • 1. Differences in treatment choices between prostate cancer patients using a decision aid and patients receiving care as usual: results from a randomized controlled trial.
    Lamers RED; Cuypers M; de Vries M; van de Poll-Franse LV; Bosch JLHR; Kil PJM
    World J Urol; 2021 Dec; 39(12):4327-4333. PubMed ID: 34272972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer.
    Lamers RE; Cuypers M; de Vries M; van de Poll-Franse LV; Ruud Bosch JL; Kil PJ
    Urol Oncol; 2017 Feb; 35(2):37.e9-37.e17. PubMed ID: 28341494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.
    van Tol-Geerdink JJ; Willem Leer J; Weijerman PC; van Oort IM; Vergunst H; van Lin EN; Alfred Witjes J; Stalmeier PF
    BJU Int; 2013 Apr; 111(4):564-73. PubMed ID: 22882966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial.
    Cuypers M; Lamers RE; Kil PJ; van de Poll-Franse LV; de Vries M
    Trials; 2015 May; 16():231. PubMed ID: 26012700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia.
    van der Wijden FC; de Angst IB; Lamers RED; Cuypers M; de Vries M; van Melick HHE; de Beij JS; Oerlemans DJAJ; van de Beek K; Kil PJM
    BJU Int; 2019 Jul; 124(1):124-133. PubMed ID: 30589205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a web-based prostate cancer treatment decision aid on patient-reported decision process parameters: results from the Prostate Cancer Patient Centered Care trial.
    Cuypers M; Lamers RED; Kil PJM; van de Poll-Franse LV; de Vries M
    Support Care Cancer; 2018 Nov; 26(11):3739-3748. PubMed ID: 29752528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer.
    Eccles BK; Cross W; Rosario DJ; Doble A; Parker C; Logue J; Little L; Stanton L; Bottomley D
    BJU Int; 2013 Aug; 112(3):330-7. PubMed ID: 23826842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy.
    Ihrig A; Keller M; Hartmann M; Debus J; Pfitzenmaier J; Hadaschik B; Hohenfellner M; Herzog W; Huber J
    BJU Int; 2011 Oct; 108(8):1274-8. PubMed ID: 21410634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head to head randomized trial of two decision aids for prostate cancer.
    Fagerlin A; Holmes-Rovner M; Hofer TP; Rovner D; Alexander SC; Knight SJ; Ling BS; A Tulsky J; Wei JT; Hafez K; Kahn VC; Connochie D; Gingrich J; Ubel PA
    BMC Med Inform Decis Mak; 2021 May; 21(1):154. PubMed ID: 33980208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a decision aid on newly diagnosed prostate cancer patients' understanding of the rationale for active surveillance.
    Formica MK; Wason S; Seigne JD; Stewart TM
    Patient Educ Couns; 2017 May; 100(5):812-817. PubMed ID: 27923674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision Aids Can Support Cancer Clinical Trials Decisions: Results of a Randomized Trial.
    Politi MC; Kuzemchak MD; Kaphingst KA; Perkins H; Liu J; Byrne MM
    Oncologist; 2016 Dec; 21(12):1461-1470. PubMed ID: 27511904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Centered Preference Assessment to Improve Satisfaction With Care Among Patients With Localized Prostate Cancer: A Randomized Controlled Trial.
    Jayadevappa R; Chhatre S; Gallo JJ; Wittink M; Morales KH; Lee DI; Guzzo TJ; Vapiwala N; Wong YN; Newman DK; Van Arsdalen K; Malkowicz SB; Schwartz JS; Wein AJ
    J Clin Oncol; 2019 Apr; 37(12):964-973. PubMed ID: 30860943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decision aid versus shared decision making for prostate cancer screening: results of a randomized, controlled trial.
    Stamm AW; Banerji JS; Wolff EM; Slee A; Akapame S; Dahl K; Massman I I I JD; Soung MC; Pittenger KR; Corman JM
    Can J Urol; 2017 Aug; 24(4):8910-8917. PubMed ID: 28832310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Decision Aid to Support Informed Choices for Patients Recently Diagnosed With Prostate Cancer: A Randomized Controlled Trial.
    Chabrera C; Zabalegui A; Bonet M; Caro M; Areal J; González JR; Font A
    Cancer Nurs; 2015; 38(3):E42-50. PubMed ID: 25010250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.
    Bergengren O; Garmo H; Bratt O; Holmberg L; Johansson E; Bill-Axelson A
    Eur Urol Oncol; 2018 May; 1(1):37-45. PubMed ID: 31100227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium.
    Diefenbach MA; Marziliano A; Tagai EK; Pfister H; Lapitan E; Hall SJ; Vira M; Ibrahim S; Aibel K; Kutikov A; Horwitz EM; Miyamoto C; Reese AC; Miller SM
    J Med Internet Res; 2023 Oct; 25():e46552. PubMed ID: 37862103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal regret and information satisfaction after deciding on treatment for localized prostate cancer with or without a decision aid. Results at one-year follow-up in the PCPCC trial.
    Cuypers M; Lamers RED; Kil PJM; van de Poll-Franse LV; de Vries M
    Patient Educ Couns; 2019 Mar; 102(3):424-428. PubMed ID: 30314830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing a decision aid to support informed choices for newly diagnosed patients with localized prostate cancer.
    Chabrera C; Font A; Caro M; Areal J; Zabalegui A
    Cancer Nurs; 2015; 38(1):E55-60. PubMed ID: 24831045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial.
    Feldman-Stewart D; Tong C; Siemens R; Alibhai S; Pickles T; Robinson J; Brundage MD
    Med Decis Making; 2012; 32(4):616-26. PubMed ID: 22287534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decision support for men with prostate cancer: Concordance between treatment choice and tumor risk.
    Filson CP; Hong F; Xiong N; Pozzar R; Halpenny B; Berry DL
    Cancer; 2021 Jan; 127(2):203-208. PubMed ID: 33119142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.